Header Logo

Connection

NATHAN FOWLER to Chemotherapy-Induced Febrile Neutropenia

Back to Details
This is a "connection" page, showing publications NATHAN FOWLER has written about Chemotherapy-Induced Febrile Neutropenia.
NATHAN FOWLER
Connection Strength
0.154
Chemotherapy-Induced Febrile Neutropenia
  1. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Cancer. 2018 06 15; 124(12):2561-2569.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.